Literature DB >> 30821627

Retinopathy of prematurity in Africa: a systematic review.

Daniel Wang1, Roseline Duke2, Rv Paul Chan3, J Peter Campbell4.   

Abstract

Purpose: Retinopathy of prematurity (ROP) is widely regarded worldwide as a major cause of childhood blindness, however until recently the disease has not been recognized in most of the African continent. As a result of changing economic conditions, there is growing evidence that the population at risk for ROP in Africa is increasing. This report aims to summarize the published literature on ROP from Africa.
Methods: We performed a systematic literature review of the English and French online literature databases by applying a general search strategy initially on May 1, 2017 with repeat inquiry on May 20, 2018. Search phrases included multiple variants of terms including "ROP", "retinopathy of prematurity", in conjunction with each of the individual 54 recognized sovereign African states. Findings: A total of 25 individual studies from six African nations were identified: South Africa (10), Egypt (7), Nigeria (4), with the nations of Sudan, Rwanda, and Kenya each having one respective study. Two countries (South Africa and Kenya) have developed national ROP policies for primary and secondary prevention. Summary: Review of the published literature suggests that ROP is emerging in Africa, however, there are published data from 6/54 (11%) African nations. Blindness from ROP is often preventable with appropriate primary and secondary prevention. This report provides compelling evidence that these efforts should be undertaken to implement and evaluate regionally appropriate ROP prevention programs in a growing number of African countries.

Entities:  

Keywords:  Retinopathy of prematurity; Sub Saharan Africa; childhood blindness; prematurity

Mesh:

Year:  2019        PMID: 30821627      PMCID: PMC6759209          DOI: 10.1080/09286586.2019.1585885

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  32 in total

1.  Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries.

Authors:  Hikmet Başmak; Leyla Niyaz; Afsun Sahin; Nazmiye Erol; Haluk H Gürsoy
Journal:  Eur J Ophthalmol       Date:  2010 Jul-Aug       Impact factor: 2.597

2.  Retinopathy of prematurity in middle-income countries.

Authors:  C Gilbert; J Rahi; M Eckstein; J O'Sullivan; A Foster
Journal:  Lancet       Date:  1997-07-05       Impact factor: 79.321

3.  Retinopathy of prematurity in South Africans at a tertiary hospital: a prospective study.

Authors:  I Mayet; C Cockinos
Journal:  Eye (Lond)       Date:  2006-01       Impact factor: 3.775

4.  Retinopathy of prematurity in a cohort of neonates at Groote Schuur Hospital, Cape Town, South Africa.

Authors:  Q Keraan; C Tinley; A Horn; T Pollock; J Steffen; Y Joolay
Journal:  S Afr Med J       Date:  2016-12-21

5.  Causes of severe visual impairment and blindness in children in schools for the blind in Ethiopia.

Authors:  A B Kello; C Gilbert
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

6.  New Ballard Score, expanded to include extremely premature infants.

Authors:  J L Ballard; J C Khoury; K Wedig; L Wang; B L Eilers-Walsman; R Lipp
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

7.  Causes of childhood blindness in east Africa: results in 491 pupils attending 17 schools for the blind in Malawi, Kenya and Uganda.

Authors:  C E Gilbert; M Wood; K Waddel; A Foster
Journal:  Ophthalmic Epidemiol       Date:  1995-06       Impact factor: 1.648

8.  Retrospective data on causes of childhood vision impairment in Eritrea.

Authors:  Rajendra Gyawali; Bharat Kumar Bhayal; Rabindra Adhikary; Arjun Shrestha; Rabindra Prasad Sah
Journal:  BMC Ophthalmol       Date:  2017-11-22       Impact factor: 2.209

9.  Retinopathy of prematurity: a study of prevalence and risk factors.

Authors:  Abdel H A A Hakeem; Gamal B Mohamed; Mohamed F Othman
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep

10.  Retinopathy of prematurity in port harcourt, Nigeria.

Authors:  Adedayo O Adio; Rosemary O Ugwu; Chidi G Nwokocha; Augusta U Eneh
Journal:  ISRN Ophthalmol       Date:  2014-02-04
View more
  6 in total

Review 1.  Impact and Trends in Global Ophthalmology.

Authors:  Lloyd B Williams; S Grace Prakalapakorn; Zubair Ansari; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2020-06-22

2.  Analysis of a two-year independent screening effort for retinopathy of prematurity in rural Egypt.

Authors:  Sara Tawfik; Ahmed Mansour; Norhan Lotfy Selim; Ahmed M Habib; Yousef A Fouad; Mohamed A Tawfik; Mariam Al-Feky
Journal:  BMC Ophthalmol       Date:  2021-12-27       Impact factor: 2.209

Review 3.  Respiratory distress syndrome management in resource limited settings-Current evidence and opportunities in 2022.

Authors:  Osayame A Ekhaguere; Ikechukwu R Okonkwo; Maneesh Batra; Anna B Hedstrom
Journal:  Front Pediatr       Date:  2022-07-29       Impact factor: 3.569

4.  Retinopathy of Prematurity in the University of Calabar Teaching Hospital, Calabar, Nigeria: An Early Report of a Screening Service.

Authors:  Elizabeth D Nkanga; Chineze Thelma Agweye; Bassey Archibong Etim; Sunny Oteikwu Ochigbo; Martha-Mary Ekong Udoh; Dennis George Nkanga; Jacob Jackson Udoh; Kelly Olalekan Asam-Utiin
Journal:  J West Afr Coll Surg       Date:  2022-07-22

5.  Profile, Visual Presentation and Burden of Retinal Diseases Seen in Ophthalmic Clinics in Sub-Saharan Africa.

Authors:  Dennis Nkanga; Olukorede Adenuga; Ogugua Okonkwo; Wilson Ovienria; Affiong Ibanga; Chineze Agweye; Idris Oyekunle; Toyin Akanbi
Journal:  Clin Ophthalmol       Date:  2020-03-04

6.  Comparative Analysis Reveals Novel Changes in Plasma Metabolites and Metabolomic Networks of Infants With Retinopathy of Prematurity.

Authors:  Yuhang Yang; Qian Yang; Sisi Luo; Yinsheng Zhang; Chaohui Lian; Honghui He; Jian Zeng; Guoming Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.